Monday, 18 Feb 2019

You are here

Improved Survival with Renal Transplant in SLE

The Annals of Internal Medicine has published a cohort study of lupus nephritis (LN) patients with end-stage renal disease (ESRD), showing that renal transplantation is associated with improved survival benefit, with a reduction in death from cardiovascular (CV) disease and infection.

A nationwide cohort study analyzed the national database of nearly all patients with ESRD (United States Renal Data System) and looked at those with incident LN-ESRD who were waitlisted for a renal transplant.

Of the 9659 patients with wait-listed LN-ESRD, 5738 (59%) had a renal transplant.

Transplantation was associated with a reduction in:

  • All-cause mortality (adjusted HR, 0.30 [95% CI, 0.27 to 0.33])
  • CV death (adj. HR 0.26 [CI, 0.23 to 0.30]
  • Death from coronary heart disease 0.30 (CI, 0.19 to 0.48) for ,
  • Death from infection 0.41 (CI, 0.32 to 0.52)
  • Death from Sepsis (aHR 0.41 (CI, 0.31 to 0.53) 

Renal transplant was associated with a significant survival benefit and highlights the benefit of timely referral for LN-ESRD patients needing transplantation.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Mortality and Hospitalization with Pulmonary Hypertension in Systemic Sclerosis

PHAROS is a prospective cohort studying the natural history of pulmonary hypertension (PH) in systemic sclerosis (SSc). They have shown that risk factors for poor outcomes in this cohort included male sex, DLCO < 50%, exercise oxygen desaturation, and pericardial effusions. 

Noninfectious Proximal Aortitis Needs Serial Follow-ups

A Cleveland Clinic review of patients undergoing thoracic aortic surgery (1996‐2012) identified 196 patients with histopathology‐proven non‐infectious aortitis. The majority of these patients had a recognized systemic disorder, and serial assessments and imaging is crucial to an accurate diagnosis.

Ten Contemporary Challenges Facing Lupus Treatment

A group of French researchers have pooled their interests to identify the challenges ahead in the management of patients with systemic lupus erythematosus (SLE). 

Elevated Fracture Risk in Lupus

A Medicaid study of lupus (SLE) patients finds that fracture risks are elevated in low‐income SLE and lupus nephritis patients compared to those without SLE.

A cohort study matched Medicaid SLE patients and age‐ and sex‐matched non‐SLE comparators to study the primary outcome of fracture of the pelvis, wrist, hip, or humerus.

Major Challenges for Lupus in 2019

Despite striking improvements in survival among patients with systemic lupus erythematosus (SLE) in recent decades -- from 1-year survival of less than 50% before the introduction of prednisone to 90% today in most specialized treatment centers -- many challenges remain in this perplexing, multisystem disease.